Biotech Values

[DewDiligence]

IDIX: Lincoln, NE is where MDS Pharma Services (a CRO to conduct clinical trials) is located.

CRO’s that run phase-1 and DDI trials probably like to locate their facilities near major universities.

The timeline shown in clinicaltrials.gov for the IDX184+IDX320 DDI study is unusually aggressive: the listing shows an expected completion date of Jul 2010 for the “primary endpoint” analysis. If MDS is running the trial, they must be confident they can recruit the requisite 20 subjects expeditiously to have entered such an aggressive timeline into the database.